Drug Information

Drug General Information
Drug ID
D04XGX
Former ID
DNC009121
Drug Name
2-(2-Methoxybenzyl)-3H-benzo[f]chromen-3-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530009]
Structure
Download
2D MOL

3D MOL
Formula
C21H16O3
Canonical SMILES
COC1=CC=CC=C1CC2=CC3=C(C=CC4=CC=CC=C43)OC2=O
InChI
1S/C21H16O3/c1-23-19-9-5-3-7-15(19)12-16-13-18-17-8-4-2-6-14(17)10-11-20(18)24-21(16)22/h2-11,13H,12H2,1H3
InChIKey
VCXYTPBLXWPGOC-UHFFFAOYSA-N
PubChem Compound ID
44592011
Target and Pathway
Target(s) Cannabinoid receptor 2 Target Info Inhibitor [530009]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 530009Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.
Ref 530009Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.